ATE180781T1 - Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung - Google Patents

Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung

Info

Publication number
ATE180781T1
ATE180781T1 AT92908325T AT92908325T ATE180781T1 AT E180781 T1 ATE180781 T1 AT E180781T1 AT 92908325 T AT92908325 T AT 92908325T AT 92908325 T AT92908325 T AT 92908325T AT E180781 T1 ATE180781 T1 AT E180781T1
Authority
AT
Austria
Prior art keywords
preparation
hydrochloride monohydrate
tiagabine hydrochloride
crystalline tiagabine
crystalline
Prior art date
Application number
AT92908325T
Other languages
English (en)
Inventor
Henning Petersen
Peter Nielsen
Michael Cain
R Subhash Patel
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE180781T1 publication Critical patent/ATE180781T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
AT92908325T 1991-04-02 1992-03-23 Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung ATE180781T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK91582A DK58291D0 (da) 1991-04-02 1991-04-02 Krystalinsk stof og dets fremstilling

Publications (1)

Publication Number Publication Date
ATE180781T1 true ATE180781T1 (de) 1999-06-15

Family

ID=8095193

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92908325T ATE180781T1 (de) 1991-04-02 1992-03-23 Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung

Country Status (15)

Country Link
US (1) US5354760A (de)
EP (1) EP0579681B1 (de)
AT (1) ATE180781T1 (de)
AU (1) AU661483B2 (de)
CA (1) CA2107223C (de)
DE (1) DE69229339T2 (de)
DK (2) DK58291D0 (de)
ES (1) ES2134801T3 (de)
FI (1) FI110096B (de)
GR (1) GR3030919T3 (de)
IL (1) IL101358A (de)
NO (1) NO304113B1 (de)
NZ (1) NZ242191A (de)
WO (1) WO1992017473A1 (de)
ZA (1) ZA922297B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750140A (en) * 1994-05-20 1998-05-12 Novo Nordisk A/S Transdermal delivery of tiagabine
JP3195360B2 (ja) * 1995-05-05 2001-08-06 ノボ ノルディスク アクティーゼルスカブ チアガビン塩酸塩を含有する医薬組成物およびその製法
AU736514B2 (en) * 1995-07-13 2001-07-26 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Non-allosteric gabaa agonists for treating sleep disorders
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
UA52661C2 (uk) * 1996-06-14 2003-01-15 Ново Нордіск А/С Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
US6410520B2 (en) 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
EP2266590A3 (de) 2002-02-22 2011-04-20 Shire LLC Wirkstoff-Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Wirkstoffen
CN1314684C (zh) * 2003-12-24 2007-05-09 中国科学院上海有机化学研究所 噻加宾及其消旋体和s－构型的合成方法及其无定形粉末的制法
US7667042B2 (en) * 2003-12-24 2010-02-23 Sun Pharma Advanced Research Company Ltd. Stable polymorphic forms of an anticonvulsant
WO2005092886A1 (en) * 2004-03-29 2005-10-06 Ranbaxy Laboratories Limited Process for the preparation of amorphous form of tiagabine
WO2006013550A2 (en) * 2004-08-04 2006-02-09 Ranbaxy Laboratories Limited Process for preparation of piperidine carboxylic acid
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US20080064727A1 (en) * 2006-08-18 2008-03-13 Cephalon, Inc. Crystalline forms of tiagabine hydrochloride
US20080051435A1 (en) * 2006-08-18 2008-02-28 Cephalon, Inc. Crystalline and amorphous forms of tiagabine
CN101857591B (zh) * 2009-04-09 2013-06-05 北京京卫燕康药物研究所有限公司 盐酸噻加宾晶型及其制备方法
CN103554093B (zh) * 2013-11-12 2015-10-21 四川科瑞德凯华制药有限公司 噻加宾乙酯盐酸盐及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof

Also Published As

Publication number Publication date
DK0579681T3 (da) 1999-11-15
FI934298A (fi) 1993-09-30
DE69229339D1 (de) 1999-07-08
AU1641592A (en) 1992-11-02
CA2107223C (en) 2005-02-15
NO933524L (no) 1993-10-01
ES2134801T3 (es) 1999-10-16
FI110096B (fi) 2002-11-29
AU661483B2 (en) 1995-07-27
IL101358A (en) 1996-08-04
DK58291D0 (da) 1991-04-02
FI934298A0 (fi) 1993-09-30
IL101358A0 (en) 1992-11-15
US5354760A (en) 1994-10-11
EP0579681A1 (de) 1994-01-26
JPH06506209A (ja) 1994-07-14
EP0579681B1 (de) 1999-06-02
NO933524D0 (no) 1993-10-01
NZ242191A (en) 1994-07-26
ZA922297B (en) 1992-12-30
DE69229339T2 (de) 1999-12-30
CA2107223A1 (en) 1992-10-03
WO1992017473A1 (en) 1992-10-15
NO304113B1 (no) 1998-10-26
GR3030919T3 (en) 1999-11-30

Similar Documents

Publication Publication Date Title
ATE180781T1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
ATE269290T1 (de) Benzoylderivate
ES2191048T3 (es) Derivados de oxazolidinona y compuestos farmaceuticos que los contienen.
PT915898E (pt) Forma i cristalina de claritromicina
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
NO20075066L (no) Farmasoytisk sammensetning som inneholder isoflavoner
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
ZA979961B (en) 5-HT1F agonists
NO996108L (no) 9-oksinerytromycinderivater
SE9702564D0 (sv) New compounds
NO971625L (no) Nye peptider med immunomodulatoriske effekter
IL99471A0 (en) Pharmaceutical compositions containing pyridylmethylsulphinyl-1h-benzimidazole derivatives as active ingredient therein
DE68924722D1 (de) Substituiertes Benzoxazinorifamycinderivat, Verfahren zur Herstellung und dieses Derivat enthaltende Bakterizidmittel.
DE69330601D1 (de) Serotoninergische ergolin derivate
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
ATE196631T1 (de) Xamonelin-tartrat
NO921491L (no) Indol- og dihydrokinolinaapnere for kaliumkanal
YU26001A (sh) Derivati ureidopiperidina kao selektivni antagonisti ljudskih nk3 receptora
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents